Učitavanje...
Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae
BACKGROUND: Tigecycline is regarded as a last resort treatment for carbapenem-resistant Enterobacter cloacae (CREC) infections, and increasing numbers of tigecycline- and carbapenem-resistant E. cloacae (TCREC) isolates have been reported in recent years. However, risk factors and clinical impacts o...
Spremljeno u:
| Izdano u: | Infect Drug Resist |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6430992/ https://ncbi.nlm.nih.gov/pubmed/30936728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S189941 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|